Bioventix (BVXP) RNS Announcements

Add to Alert list
Date Time Source Announcement
20 Dec 2012 04:05 PM
PRN
Shareholder Notification
07 Dec 2012 03:23 PM
PRN
Shareholder Notification
05 Dec 2012 10:02 AM
PRN
Shareholder Notification
03 Dec 2012 12:02 PM
PRN
Shareholder Notification
09 Nov 2012 02:23 PM
PRN
Notice of AGM
25 Sep 2012 07:00 AM
PRN
Final Results
12 Mar 2012 07:00 AM
PRN
Interim Results for 6 months to 31 December 2011
04 Jan 2012 01:56 PM
PRN
Directorate Change
06 Dec 2011 09:11 AM
PRN
Result of AGM
09 Nov 2011 04:30 PM
PRN
Notice of AGM
08 Nov 2011 02:44 PM
PRN
Director/PDMR Shareholding
13 Sep 2011 07:00 AM
PRN
Final Results for the year ended 30 June 2011
14 Mar 2011 11:48 AM
PRN
Interim Results to 31 December 2010
07 Jan 2011 03:42 PM
PRN
R&D and Product Update
01 Dec 2010 07:00 AM
PRN
Research and Development Update
02 Nov 2010 05:33 PM
PRN
Notice of AGM
02 Nov 2010 07:00 AM
PRN
Final Results
30 Sep 2010 10:32 AM
PRN
Total Voting Rights
02 Sep 2010 05:20 PM
PRN
Transaction in Own Shares
12 Aug 2010 05:37 PM
PRN
Dividend Declaration
07 Apr 2010 07:00 AM
PRN
Interim Results to 31 December 2009
07 Apr 2010 07:00 AM
PRN
Admission to PLUS-quoted

Bioventix plc is a biotechnology company that develops and supplies heep monoclonal antibodies for use in clinical diagnostics.

Founded in 2003, the company's products are used to test for conditions like heart disease, cancer, and fertility issues.

Bioventix share price launched at 310p in 2013.

UK 100

Latest directors dealings